Publications in collaboration with researchers from Hospital Universitario Reina Sofia (20)

2024

  1. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

    Therapeutic Advances in Gastroenterology, Vol. 17

  2. Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients

    Inflammatory Bowel Diseases, Vol. 30, Núm. 2, pp. 167-182

2023

  1. Analysis of the degree of implementation of medication error prevention practices in Spanish hospitals (2022)

    Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. 268-276

  2. Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety

    American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247

2022

  1. Alcohol use and family-related factors among Spanish university students: the unHicos project

    BMC Public Health, Vol. 22, Núm. 1

  2. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

    Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736

  3. Patterns of Alcohol Consumption and Use of Health Services in Spanish University Students: UniHcos Project

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 10

  4. Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry

    Digestive and Liver Disease, Vol. 54, Núm. 5, pp. 635-641

  5. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

    Journal of Clinical Medicine, Vol. 11, Núm. 15

2021

  1. Impact of biological agents on postsurgical complications in inflammatory bowel disease: A multicentre study of geteccu

    Journal of Clinical Medicine, Vol. 10, Núm. 19

2020

  1. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease

    United European Gastroenterology Journal, Vol. 8, Núm. 9, pp. 1056-1066

2019

  1. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study

    Journal of Crohn's & colitis, Vol. 13, Núm. 12, pp. 1492-1500

2016

  1. Stock management in hospital pharmacy using chance-constrained model predictive control

    Computers in Biology and Medicine, Vol. 72, pp. 248-255

2014

  1. Application of robust model predictive control to inventory management in hospitalary pharmacy

    19th IEEE International Conference on Emerging Technologies and Factory Automation, ETFA 2014

2012

  1. Análisis y minimización del riesgo de rotura de stock aplicado a la gestión en farmacia hospitalaria

    Farmacia Hospitalaria, Vol. 36, Núm. 3, pp. 130-134

2006

  1. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia

    Clinical Pharmacokinetics, Vol. 45, Núm. 12, pp. 1227-1238

1998

  1. Factores clínicos que influyen en la detección de transcrites BCR-ABL después del trasplante de médula ósea alogénico por leucemia mieloide crónico

    Medicina Clinica, Vol. 111, Núm. 11, pp. 405-409

1997

  1. Chimerism analysis in long-term survivor patients after bone marrow transplantation for severe aplastic anemia

    Haematologica, Vol. 82, Núm. 5, pp. 588-591

1995

  1. Molecular heterogeneity in childhood precursor b acute lymphoblastic leukemia with immunoglobulin heavy chain gene in germline configuration

    Leukemia and Lymphoma, Vol. 20, Núm. 1-2, pp. 157-160

  2. Optimal timing of granulocyte colony-stimulating factor (G-CSF) administration after bone marrow transplantation - A prospective randomized study

    Annals of Hematology, Vol. 71, Núm. 2, pp. 65-70